The world's smallest needle
The company is an Israeli commercial-stage one that developed the world’s smallest needle (microneedle).
It was the first to register such a product with the US FDA, as well as in Europe, China, Canada, Korea, Russia and Brazil, among others.
Its flagship product, the 0.6mm MicronJet600® microneedle, is a microneedle-based device that is intended for injection into the skin ("intradermal injections").
Intradermal injections are currently used for several therapeutics including aesthetics (dermal fillers, Botox, mesotherapy, lidocaine), vaccines (BCG, rabies and polio in certain countries), skin tests (PPD, allergy testing) and allergy.
Experimental products in clinical trials include vaccines (influenza, zoster and many others) and immunotherapies for cancer, allergy and diabetes.
The company is looking to expand its commercial operations by distributing its devices in select markets for high-value applications.
The benefits of the device have been proven in various clinical studies and include: easy-to-use, consistency, efficiency and near-painless delivery.
It can be used with any standard syringe to inject liquid substances directly into the skin.
Potential Partners:
Disposable device distributors, drug delievry companies, injectable aesthetic companies, allergy companies.
Target countries: US, Korea, China, France, Spain, Italy, Russia.
Company info:
Year of establishment: 2000
No. of employees: 10
